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Intelligent in vitro models able to recapitulate the physiological interactions between tis-
sues in the body have enormous potential as they enable detailed studies on specific
two-way or higher order tissue communication. These models are the first step toward
building an integrated picture of systemic metabolism and signaling in physiological or
pathological conditions. However, the rational design of in vitro models of cell–cell or cell–
tissue interaction is difficult as quite often cell culture experiments are driven by the device
used, rather than by design considerations. Indeed, very little research has been carried
out on in vitro models of metabolism connecting different cell or tissue types in a physio-
logically and metabolically relevant manner. Here, we analyze the physiological relationship
between cells, cell metabolism, and exchange in the human body using allometric rules,
downscaling them to an organ-on-a-plate device. In particular, in order to establish appro-
priate cell ratios in the system in a rational manner, two different allometric scaling models
(cell number scaling model and metabolic and surface scaling model) are proposed and
applied to a two compartment model of hepatic-vascular metabolic cross-talk. The theo-
retical scaling studies illustrate that the design and hence relevance of multi-organ models
is principally determined by experimental constraints. Two experimentally feasible model
configurations are then implemented in a multi-compartment organ-on-a-plate device. An
analysis of the metabolic response of the two configurations demonstrates that their glu-
cose and lipid balance is quite different, with only one of the two models recapitulating
physiological-like homeostasis. In conclusion, not only do cross-talk and physical stimuli
play an important role in in vitro models, but the numeric relationship between cells is also
crucial to recreate in vitro interactions, which can be extrapolated to the in vivo reality.
Keywords: allometry, in vitro models, organ-on-a-plate, metabolism, hepatocytes, endothelial cells
INTRODUCTION
Systems in which two or more organ or tissue models are con-
nected or combined together have been proposed by several
groups. These can generally be classified into three groups: co-
cultures, microscaled multi-organ or body-on-a-chip, and milli-
scaled multi-organ-on-a-plate. Most of the models reported in the
literature involve co-cultures in which two cell types are seeded
together (Turtzo et al., 2001; Zinchenko et al., 2006), or transwell
cultures in which two cell types are separated by semi-permeable
membranes (Lau et al., 2004). The more sophisticated models
use fluidic systems or bioreactors to connect the different organ
models together (Ouattara et al., 2011). A complex microfluidic
bioreactor,µCCA, was developed by Viravaidya et al. (2003) com-
bining three cell types in a multi-chamber device to test the toxicity
of naphthalene. The system was designed using pharmacokinetic-
pharmacodynamic scaling and is one of the few examples of cell
culture system design based on mechanistic mathematical models.
Such a device brings us a step closer to observing the systematic,
whole-body response to drugs rather than the response of a single
cell population, and is known as the “body-on-a-chip” approach
(Esch et al., 2011).
Ahluwalia and co-workers first described the use of the prin-
ciples of allometric scaling to establish design rules for in vitro
models representing different physiological organ–organ interac-
tions such as the lung–liver and intestinal–liver axes (Vozzi et al.,
2009; Sbrana and Ahluwalia, 2012). Since then, some reports have
speculated on the scaling of micro and milli-scaled multi-organ
devices using allometry (Wikswo et al., 2013), suggesting that
allometry breaks down at the microscale, and hence that multi-
organ on a chip devices should perhaps not be “too small.” More
recently, Moraes et al. (2013) propose a “metabolically supported
functional scaling”approach, which is very similar to the metabolic
scaling for the liver described in Sbrana and Ahluwalia (2012).
The multi-organ-on-a-chip concept has become quite popu-
lar, with several groups in the USA, Europe, and Japan attempting
to design microscaled fluidic devices for drug and toxicity testing
using more than one cell type (Zhang et al., 2009; Imura et al., 2012;
Wagner et al., 2013). Still very much a niche tool limited to labo-
ratories with microfabrication facilities and microfluidic pumps,
they have nevertheless attracted considerable interest. Some of
the practical limitations of these systems (bubbles, large surface
areas, etc.) have been highlighted in Mattei et al. (2014), who also
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FIGURE 1 | (A) Example of a MCmB circuit with three chambers, (B) A single MCmB module. Scale bar represents 10 mm.
demonstrate that the constraint of maintaining low shear stress in
microscaled fluidic devices may lead to severe glucose depletion,
even if a sufficient oxygen supply is guaranteed by the presence of
gas permeable (typically polydimethylsiloxane or PDMS) walls.
On a different scale, connected cultures of hepatocytes,
adipocytes, and endothelial cells in modular bioreactors (Figure 1)
have been used to investigate the regulation of systemic metab-
olism in vitro. The milli-scaled MCmB system on-a-plate was
designed using allometric scaling, focusing on glucose and lipid
processing for their relevance to diabetes and metabolic disorders
(Guzzardi et al., 2009). Successive investigations on the role of
adipose tissue and the effects of over-nutrition in the systemic
model were also reported (Vinci et al., 2012; Iori et al., 2012).
Milli-scaled on-a-plate devices for multi-organ cultures are com-
mercially available,but are not very widespread due to the necessity
of fluidics (pumps) and the obligation of establishing a common
culture medium.
The increasing number of papers on multi-cell and multi-organ
systems nevertheless underlines the interest in this type of study,
particularly as regards drug and toxicity testing and disease mod-
els. The underlying methodological assumption of these studies is
that by combing different cell types together, it is possible to trans-
late the results to the in vivo reality. However, most reports do
not justify the cell types used, their ratios, or the particular culture
conditions employed. On the other hand, in order to develop phys-
iologically relevant models, it is important to properly design cell
culture devices and use meaningful cell surface areas or cell ratios
according to the type of experiment being conducted. In fact, one
of the main conclusions of our studies on glucose and lipid metab-
olism was that to elicit meaningful responses, a fluidic connected
culture system requires first cell numbers and ratios, which enable
appropriate physiological-like interactions, and, second, flow rates
that do not cause shear stress-related damage to cells and that allow
adequate residence times in each compartment to enable cells to
process metabolic signals, while permitting an adequate oxygen
supply through convection (Mazzei et al., 2010).
Given the growing interest and the importance of appropriate
scaling in multi-organ systems, in this paper allometric scaling
models are proposed and applied to the study of metabolic reg-
ulation in a two compartment hepatic-endothelial model. We
considered two models: one based on cell numbers (cell num-
ber scaling model, CNSM), and the second based on metabolic
rates and cell surface areas (metabolic and surface scaling model,
MSSM). Our aim was to use rational design considerations based
on allometry to determine cell ratios in a multi-organ-on-a-plate
device and to determine if and how differences in the initial con-
ditions (i.e., cell numbers and ratios) can influence overall cell
function and metabolic response.
For the sake of completeness, we first introduce the concept of
allometric scaling and show how allometry can be used to evalu-
ate the relationships between different tissues in order to ensure
that the same relationships are conserved in a downscaled in vitro
environment. After describing allometric scaling models, in the
second part of this paper, we establish two experimentally feasible
cell ratios based on the models and test them using a modular cell
culture system specifically developed for reconstructing tissue and
organ cross-talk in vitro (Vozzi et al., 2011).
ALLOMETRIC SCALING IN IN VITRO MODELS
Allometry is the science of scaling and deals with changes in body
size and relationships among different parameters and processes in
all organisms as a function of body mass M (Lindstedt and Scha-
effer, 2002; West and Brown, 2005). The basic allometric equation
can be used to correlate physiological variables between organisms
of different sizes.
Y = a ×M b (1)
Y is the physiological parameter that has to be correlated with
body mass (M ), such as basal metabolic rate (BMR), heart rate,
life span, etc. The constant a is a proportionality factor for the par-
ticular parameter, whereas b is the allometric exponent. b varies
in magnitude and sign and has a specific value for each parame-
ter according to how it scales with mass. Table 1 explains how b
determines the manner in which physiological parameters change
with mass.
The allometric approach can be used to evaluate the relation-
ships between different tissues in order to ensure that the same
relationships are conserved in a downscaled in vitro environment.
In this paper, the approach is applied to scale a hepatic-endothelial
model in the MCmB, a Multi-compartment modular Bioreactor
system, which enables different chambers to be connected together
in a fluidic circuit (Mazzei et al., 2010). It consists of intercon-
nected chambers with dimensions similar to that of a 24-plate well,
each one designed to house a specific tissue or organ (Figure 1).
Higher order more complex models can thus be assembled by com-
bining two or more cell types or tissues connected by the flow of a
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Table 1 |The value of b determines how a physiological parameter varies with body mass.
b Significance Example (value of b)
0 Parameter does not change with body mass Bone density in mammals, cell radius
1 Parameter changes in direct proportion with body mass Body volume, cell number
0<b<1 Parameter increases at a slower rate than body mass Metabolic rate (3/4), blood flow rate (3/4), external surface area (2/3), life
span (1/4)
>1 Parameter increases at a faster rate than body mass Bone mass (4/3)
<0 Parameter decreases with body mass Almost all frequencies or rates, e.g., cardiac frequency, respiratory
frequency (−1/4)
common medium and modules can simply be added or removed
to alter the contribution of each organ in the model.
METABOLIC AND SURFACE SCALING MODEL
The liver is responsible for the uptake, conversion, and distribution
of many of the nutrients entering the digestive tract and is also the
main orchestrator of exogenous metabolism while vascular tissue
is the conduit through which signals are relayed to distant organs.
We therefore begin by connecting hepatocytes with endothelial
cells before adding other cells or tissues to construct an in vitro
model of biotransformation and distribution. Biotransformation
is a metabolic process and depends on the metabolic efficiency
of cells, whereas distribution is a surface mediated process. There-
fore, the hepatocytes in the model are scaled with reference to basal
metabolism whereas the endothelium is scaled using the surface
area of the human vascular system as a starting point. As cells
are usually plated in monolayers, the allometric design process
begins by considering the metabolism of a two dimensional cul-
ture of human hepatocytes in a single module. Hepatocytes can be
seeded on the bottom surface of the chamber (either on a slide or
a scaffold) to represent the liver of a multi-organ in vitro model.
Standard parameters and their corresponding bibliographic
references used to establish the experimental set-up in the MSSM
through allometric scaling are summarized in Table 2. The liver
generates 27% of the total BMR of a human, corresponding to
23.76 W. Then, assuming the total metabolic contribution of the
liver is due principally to its approximately 200 billion hepatocytes,
the BMR per human hepatocyte is 119 pW. The surface area of the
cell culture zone of a chamber is the same as that of a 24-plate
well: 1.33 cm2. A confluent layer of hepatocytes has a density of
about 2× 105 cells/cm2, which corresponds to 2.6× 105 cells in
the chamber (Ferrini et al., 1998), therefore the equivalent BMR of
the in vitro one chamber liver is 30µW. Since we are using human
hepatocytes in our model, we assume that their metabolic contri-
bution remains unchanged (Porter, 2001), that is they contribute
to 27% of the downscaled organism’s BMR. Thus, the total BMR
of the system with 2.6× 105 hepatocytes is 111µW (BMRin).
Allometric equations can be used in order to find the equivalent
body mass (Min) of our in vitro system. Equations 2 and 3 summa-
rize the steps required to estimate Min starting from the BMR and
the mass of the human body (BMRman and Mman, respectively).
BMRman = aBMR ×Mman3/4 (2)
BMRin = aBMR ×M 3/4in (3)
Table 2 | Summary of data used for allometric scaling of liver
(Bean, 1926; Durnin, 2002; Sohlenius-Sternbeck, 2006).
Human data Value
Body mass, Mman 70 kg
Basal metabolic rate (BMR) 88W
Liver mass 1.8 kg
Liver contribution to BMR 27%
No. of hepatocytes 2×1011
Min in this case is 1 mg. Note that this value depends very much on
the number and source of hepatocytes employed. Min can be up
to 5 mg in three-dimensional scaffolds and more in tissue slices.
Having established this parameter, the allometric approach can be
used in order to find a suitable surface area to simulate the vascular
endothelial exchange area. The allometric equation that links vas-
cular surface area (S) to body mass (M ) of a mammal is (Dawson,
2003):
S = a ×M 11/12 (4)
Note that the vascular bed is a space filling structure; therefore,
the capillary area does not follow the 2/3 scaling law, which only
holds for external surface areas. Given that capillary bed surface
of a standard man in resting conditions is 500 m2 (Kamiya et al.,
1987), we can estimate the constant a from Eq. 4 and then find
a suitable surface area to simulate the endothelium in an in vitro
experiment.
S = a × (1 mg)11/12 (5)
The surface of a chamber that represents the endothelium should
be 0.33 cm2. This is about a quarter of the cell culture area of an
MCmB module. Iterating through Eqs 2–5, it is easy to show that
if one chamber is used to simulate the exchange surface area of the
endothelium, about three to four modules have to be used to rep-
resent the liver (less if hepatocyte density is increased by seeding
on a scaffold). Note that the relationship is not linear due to the
exponent based scaling laws used.
CELL NUMBER SCALING MODEL
An alternative model is described to simulate cross-talk between
endothelial and hepatic tissue. In tissues, cell numbers play an
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important role in physiological functions. For example, cell num-
ber is an important parameter in order to characterize drug filtra-
tion or absorption rates. Thus, if the aim is to study drug passage
from one organ to another by simulating tissues as monolayers in
several bioreactor chambers connected in series or in parallel, the
cell numbers in each culture are a key point in the experimental set
up. An allometric model based on cell numbers could represent a
valid alternative to the MSS model in order to simulate cross-talk
between tissues. Vascular endothelial tissue represents 6.28% of
total body weight (NASA, 1995), while liver mass is equal to 2.6%
of human body mass.
Given that hepatocytes represent 60% of liver mass (Sohlenius-
Sternbeck, 2006), Eq. 6 enables calculation of the ratio (r) between
the body’s endothelial mass (Mendo) and hepatocyte mass (Mhep):
r = Mendo
Mhep
≈ 4 (6)
“r” represents physiological ratio between endothelial and hepato-
cyte mass in the body. If we suppose that both cells have the same
average mass, as suggested by the data on endothelium thickness
(0.3µm) and diameter (Pries et al., 2000) and hepatocyte size
(Uhal and Roehrig, 1982), then in order to maintain this correla-
tion in an in vitro experiment, the endothelial number has to be
around four times the hepatocyte cell number. This assumption is
also supported by Kozlowski et al. (2010) who demonstrate that
cell mass is size invariant in mammals.
Since endothelial cells in culture are almost three times larger
in diameter than hepatocytes in vitro (Haas and Duling, 1997;
Pries et al., 2000; Vizzotto et al., 2001), the value of r calcu-
lated results in a 36:1 ratio of endothelial:hepatic bioreactors.
Assembling 36 chambers with endothelial cells would not only
lead to large fluid volumes, which may increase metabolite dilu-
tion, but is also impractical using the MCmB modules. Therefore,
as an alternative to scaling down whole-body cell numbers, we
focused on the ratio between endothelial cells and hepatocytes in
the visceral abdominal region. This region is the first to receive
nutrients after intestinal processing and is relevant to short term
metabolism of glucose and lipids (Kuo and Ma, 2001; Iori et al.,
2012).
The abdomen represents 3.08% of body mass – most of this is
liver (Bean, 1926). Assuming that there is a uniform distribution
of vascular tissue in the body, we can evaluate abdominal vascular
tissue mass (Mavt) using the following equation:
Mavt = 0.0308× (Mman × 0.0628) (7)
Then ra, the physiological ratio between endothelial and hepato-
cyte mass in the abdomen is:
ra = Mavt
Mhep
= 0.08 ≈ 0.1 (8)
Again, to maintain this correlation in an in vitro experiment, the
number of endothelial cells has to be around 1/10 of the hepato-
cyte number, but in this case the value of ra calculated conveniently
results in a 1:1 ratio of bioreactors when employing monolayer
monocultures.
WHOLE BODY AND ABDOMINAL MSSM AND CNSM
For the sake of comparison, we show how the two models differ in
surface area and cell number for both whole body and abdominal
compartments in Table 3. The table underlines how the choice
of models is inevitably conditioned by experimental and practical
constraints related to the cell culture system being employed.
For example, from Table 3 it is clear that the abdominal
MSSM would necessitate either 57 hepatic chambers or several
high density 3D hepatocyte cultures to implement. Given the very
high hepatic cell number in the abdominal model, liver metab-
olism would likely predominate with respect to any endothelial
related uptake or release of metabolites. On the other hand,
the whole-body MSSM can be assembled simply by connecting
together four 24-well-sized modular chambers seeded with mono-
layers of hepatocytes and one chamber seeded with endothelial
cells. Vice-versa, as demonstrated, the CNSM for the whole body
requires tens of endothelial chambers, while the abdominal model
with its 1:1 hepatocyte to endothelial module ratio, is simple
to set-up.
The main difference between the two models is that the MSSM
considers whole-body metabolism and nutrient distribution and
gives more weight to hepatic metabolism than the CNSM, since
b= 3/4 for metabolism and almost 1 (11/12) for vascular surface
area (see Table 1). On the other hand, the CNSM simply considers
the mass ratios, independent of cell function. As the liver is the
predominant metabolic organ in the visceral region, were we to
evaluate the chamber ratios using MSSM for just the abdomen,
we would require a large number of hepatocytes with respect to
endothelial surface area.
In the following section, we describe the hepatic-endothelial
experiments based on the two practicable allometric models
(respectively the whole-body MSSM and the abdominal CNSM)
in the MCmB system and show how changing cell numbers and
ratios can condition experimental outcomes.
Table 3 | Comparison between the metabolic and cell number scaling models for the whole body and the abdominal region using monolayer
cultures in the MCmB system. The table underlines that the choice of model is strongly conditioned by experimental constraints.
MSSM CNSM
Hepatocytes Endothelial area Hepatocytes Endothelial cells
Whole Body 1040000 cells (4 chambers) 1.33 cm2 (1 chamber) 260000cells (1 chamber) 942000 cells (36 chambers)
Abdominal 15×106 cells (57 chambers) 1.33 cm2 (1 chamber) 260000 cells (1 chamber) 26000 cells (1 chamber)
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EXPERIMENTAL
MATERIALS
Eagle’s Minimum Essential Medium (EMEM), Penicillin/Strepto-
mycin/Amphotericin B, l-Glutamine was purchased from Lonza
Bioscience (Basel, Switzerland). Fetal bovine serum (FBS) was pur-
chased from PAA (Pasching, Austria); all other reagents were pur-
chased from Sigma-Aldrich (St. Louis, MI, USA) unless otherwise
specified.
ENDOTHELIAL EXTRACTION AND CULTURE
Human umbilical vein endothelial cells (HUVEC) were extracted
from donor umbilical cords using collagenase solution treatment
following the protocol from Baudin et al. (2007). A single donated
umbilical cord was sufficient for all the experiments. They were
donated through written and informed consent and the study was
approved by the local ethical committee.
The medium for culturing endothelial cells was EMEM
(with 5 mM glucose) supplemented with 10% FBS, 1% Peni-
cillin/Streptomycin/Amphotericin B, 2 mM L-Glutamine; 1%
non-essential amino acids 100×; 1% MEM vitamins solution;
10µg/mL endothelial cell growth supplement (ECGS), 10 ng/mL
human epidermal growth factor (hEGF); 3 ng/mL basic fibroblast
growth factor (bFGF); 1µg/mL hydrocortisone,10µg/mL heparin
sodium salt and (henceforth named the “common” medium). The
endothelial cells were routinely trypsinized and used between the
third and eighth cell passages.
Twenty-four hours before the experiment, the cells were seeded
at a confluent concentration of 20,000 cells/cm2 on 13 mm
diameter plastic slides (Nunc, Denmark) precoated with 1%
gelatin.
HEPATOCYTE CULTURE
The human hepatoma-derived cell line C3A (ATCC Culture,
USA) was used in the experiments as this cell line retains
most endogenous metabolic functions of human hepatocytes.
Cells were cultured in EMEM with 10% FBS, 1% Peni-
cillin/Streptomycin/Amphotericin B, 1% l-Glutamine 200 mM;
1% non-essential amino acids 100×, and 1% MEM vitamins solu-
tion (named complete EMEM). The C3A hepatocytes were seeded
at a near confluent density of 200,000 cells/cm2 on glass cover-
slips. Before seeding, the glass coverslip was coated with collagen:
200µL of 0.2 mg/mL of type I collagen was pipetted and allowed
to cross link for about 30 min at 37°C. Collagen was prepared by
extracting acid-soluble collagen from rat tail tendons (Beken et al.,
1998).
DYNAMIC CELL CULTURE
In this work, we used four (monolayer) hepatocyte chambers
and one endothelial chamber to represent whole-body MSSM
type scaling. The abdominal CNSM configuration was composed
of one hepatocyte chamber and one endothelial chamber. All
dynamic experiments were carried out in five MCmB modules
connected in series as shown in Figure 2. For the MSSM, one
endothelial cell coated slide was placed in the bottom of the first
chamber and four hepatocyte slides were transferred to each of
the other chambers of the system (Figure 2A). In the CNSM, one
endothelial slide was placed in the bottom of the first chamber
and one hepatocyte slide in the second chamber, the other three
chambers were left empty of cells (Figure 2B). Each bottom part
of the chamber was filled with 500µL of common media in order
to avoid drying of cells during assembly of the system. The rest
of the common media (15 mL in total, necessary to fill the cir-
cuit and avoid nutrient depletion) was added to the mixing bottle.
The circuits were closed and connected to a pump (Ismatech IPC-
4, Zurich, Switzerland) and run at 100µL/min in the incubator
for 72 h.
As static controls, and to assess the effects of flow, the same
number of coverslips were placed in a Petri dish with 15 mL
of common medium and incubated for the same experimental
time. Note that the volume of media was kept the same in all
experiments, to reduce the number of variables in the system.
ASSAYS
At the end of the experiment, cells were analyzed for viability,
morphology, and cytochrome activity. Viability was assessed by
the CellTiter-Blue® Cell Viability Assay (Promega) and compared
with internal controls in multiwell plates. After viability evalua-
tion, hepatocytes were also analyzed for Cytochrome P450 enzyme
activity by VIVID® CYP3A4 Red Screening Kit (Invitrogen Ltd,
Paisley, UK); the increase in fluorescence emission after substrate
addition is a measure of CYP3A4 activity. Cell morphology was
assessed using phase contrast microscopy. The medium was ana-
lyzed for glucose (Glucose Test Kit, Megazyme International Ltd,
Ireland), urea (Urea Kit, Sigma-Aldrich), lactate, glycerol, triglyc-
erides (TG), and free fatty acids (FFA) (Lactate, Free Glycerol Assay
kit, Triglyceride quantification kit, and Free Fatty Acid Quan-
tification Kit were all from Biovision Inc., Milpitas, CA, USA).
Human albumin concentration was determined by an ELISA
immunochemical assay (Bethyl Laboratories, Montgomery, USA).
DATA ANALYSIS
Results were calculated from at least three different experiments
and expressed as means± SD of the mean. Data were analyzed
using the Student’s t -test. Statistical significance was set at p< 0.05
(indicated with *) and high significance was set at p< 0.01
(marked with **).
RESULTS
A number of metabolic and functional assays were performed
to assess the differences between the two cell ratios used in the
experiments. All results are expressed as the difference between
measured values and fresh media values. When the measured value
was higher than that of fresh media, we denote this as release while
measured values lower than fresh medium are denoted as uptake.
VIABILITY AND P450 ACTIVITY
Viability and P450 activity were evaluated on each cell coated cov-
erslip. Both cell types in both experimental models showed high
viability, with very little scatter. The vitality values were within 15%
of the initial vitality, indicating that cell numbers remained essen-
tially constant during the experiments. There was no difference
in hepatocyte P450 activity in all conditions (data not shown).
Furthermore, hepatocyte morphology was similar to that of our
static controls (Figure 3A), with endothelial cells conserving a
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FIGURE 2 |The MCmB connection scheme for the whole-body MSSM (A) and the abdominal CNSM (B).
FIGURE 3 | Morphology of C3A cells (A) and HUVEC cells in static (B) and dynamic (C) conditions.
cobblestone-like morphology in static experiments and a slightly
more elongated form in dynamic experiments (Figures 3B,C).
CARBOHYDRATE METABOLISM
Carbohydrates are the primary source of energy and metabolic
intermediates. Glucose is the main carbohydrate used by the cell
in both aerobic and anaerobic respiration. Hepatocytes are able to
store or release glucose through glycogen synthesis or glycolysis
pathways. Glucose dosing in the media showed a higher uptake in
the MSSM configuration. In both static and dynamic conditions,
the higher consumption of glucose can be attributed to the higher
number of cells with respect to the CNSM model (approximately
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FIGURE 4 | (A) Glucose uptake and (B) Lactate release in the two allometric model configurations. Static samples were the same type and number of cells
cultivated in a petridish. Mean±SD, *p<0.05, **p<0.01, n=3.
FIGURE 5 | (A) Triglyceride uptake, (B) FFA uptake, and (C) glycerol uptake from cells in the two allometric model configurations. Static samples were the same
type and number of cells cultivated in a petridish. Mean±SD, *p<0.05, **p<0.01, n=3.
threefold more). Significant (p< 0.01) differences were observed
between the two models in static conditions (Figure 4A). Lac-
tate levels are a function of both glycolysis and gluconeogenesis in
hepatocytes (Phillips et al., 1995), and are known to be down reg-
ulated by circulating (in vivo) or media FFAs (in vitro) (Morand
et al., 1993). A significant (p< 0.05) decrease of lactate release
in dynamic conditions was observed. No difference was found
between the two models even when relating lactate release with
glucose uptake: similar concentrations of lactate were found in
both configurations despite the lower uptake of glucose in the
CNSM (Figure 4B).
FAT METABOLISM
The liver has a major role in the regulation both of glucose metab-
olism and fat metabolism. It can either oxidize or synthesize fatty
acids and TG directing them to energy production or to storage.
FFA and glycerol provided by ingestion or by drawing on TG are
used as substrates for ATP production.
Triglyceride dosing showed that cells in the CNSM configu-
ration took up about twice as much triglyceride content as the
MSSM even though the total amount of cells present in the system
was four times less. No significant change was observed between
the static and dynamic set up in both models (Figure 5A).
Free fatty acids data showed a variable trend between the two
configurations. In the MSSM configuration, high FFA uptake was
observed for the static set up with a lower uptake in the dynamic
set up. In the CNSM, the slight uptake in static conditions was
contrasted by a highly significant release in the dynamic config-
uration (Figure 5B). This inversion of the trend is likely caused
by endothelial cells. In previous studies on endothelial cells, we
observed high levels of FFA release in dynamic conditions com-
pared with static experiments, whereas hepatocytes take up FFA in
both static and dynamic conditions (Vinci et al., 2010). Finally, the
same level of glycerol was taken up by cells both static and dynamic
states in the two configurations, with an overall lower uptake in
the CNSM with respect to MSSM (Figure 5C).
FUNCTIONAL MARKERS
Healthy hepatocytes are able to perform carbohydrate, lipid, and
xenobiotic metabolism, they also synthesize several molecules
including albumin, and convert ammonia into urea. High lev-
els of albumin and urea are considered to be positive indicators of
hepatic function. A significant increase in albumin release was
detected in the CNSM configuration where, despite the lower
number of C3A, the cells release twice more albumin than in the
MSSM. The content of albumin in each configuration was similar
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FIGURE 6 | (A) Albumin release and (B) urea release from cells in the two allometric model configurations. Static samples were the same type and number of
cells cultivated in a petridish. Data reported as concentration per coverslip; mean±SD, *p<0.05 and **p< 0.01, n=3.
in static and dynamic conditions (Figure 6A). Urea release had
the same trend as albumin, as shown in Figure 6B. Significantly
higher amounts of urea were released from cells in the CNSM
configuration (p< 0.01) and even more in the dynamic set up
(p< 0.05).
DISCUSSION
In this study, two allometric models were used to scale meta-
bolic interactions in the hepatic-endothelial axis in order to define
rational design criteria for establishing cell ratios in a multi-organ-
on-a-plate system. The CNSM was based on the scaling of cell
numbers, while the MSSM was derived from considerations on
hepatic metabolism and endothelial exchange. Using human data
as a starting point, the results of allometric downscaling demon-
strate that the cell ratios are considerably different for the two
models and, as expected, depend on whether the whole body
or core hepatic-endothelial axis is considered. In addition, the
results in Table 3 show that only two models are feasible in the
multi-organ-on-a-plate system under investigation.
The two practicable models were then evaluated experimentally
to identify which of the two cell ratios better represents a more
physiological state in terms of overall cell function and nutrient
metabolism. The two systems examined represent, respectively,
an allometrically scaled metabolic and surface area based scal-
ing model of the whole-body relationship between endothelial
cells and hepatocytes, and a model which albeit allometric, simply
reflects the proportion of hepatocytes to endothelial cells in the
abdomen.
Cell viability, P450 activity, and cell morphology were similar
in both models, indicating that differences in cell ratios did not
alter intrinsic cell function but rather their metabolic cross-talk.
The analysis was thus centered on the balance between glucose and
lipid concentrations in the media and the capacity of the system
to recapitulate a physiological energy balance.
Overall, cells in the MSSM took up more glucose from the
medium (Figure 4A). However, if we consider the glucose uptake
per cell, then cells in the CNSM dynamic set up consume more glu-
cose per cell with respect to the MSSM, but were nonetheless able
to maintain glucose levels closer to normoglycaemic (~3 mM).
Similarly, higher amounts of lactate per cell were released in
the CNSM, reflecting the increased glucose uptake, and reaching
total lactate concentrations similar to the MSSM configuration
(Figure 4B).
The second most important mechanism for energy produc-
tion in humans is fat metabolism. Significantly (p< 0.01) higher
triglyceride uptake was shown in the CNSM (Figure 5A), resulting
in a media triglyceride concentration per cell in the dynamic set
up of about eightfold less with respect to the concentration per cell
in the MSSM. This suggests that cells in the CNSM were undergo-
ing higher triglyceride turnover than in the MSSM, so indicating
that in the CNSM cells were producing energy by lipid metabo-
lism at a higher level than in the MSSM. The FFA uptake results
are also interesting and highly significant (p< 0.01) (Figure 6B).
Vinci et al. (2010) have shown that FFA uptake in hepatocytes
does not differ between the static and dynamic set up; in contrast
endothelial cells are highly sensitive to flow and the FFA turnover
is inverted: the cells uptake FFA in static conditions and release
it in high amounts under flow conditions. Keeping this in mind,
the data in Figure 5B, can be interpreted as an additive effect with
both a hepatic and endothelial contribution. In static conditions,
the uptake of FFA is due to hepatocytes, which are present in higher
numbers than endothelial cells in both models. In fact, FFA uptake
is higher in the MSSM (sixfold more) than that in CNSM, which
has fewer cells. In dynamic conditions where endothelial cells com-
peted with hepatocytes in the direction of FFA movement, lower
uptake was shown in the MSSM as number of endothelial cells
releasing FFA cannot overpass the high uptake of hepatocytes.
On the other hand, the FFA trend was inverted in the dynamic
CNSM configuration, where high FFA release from endothelial
cells overrode the hepatic uptake, resulting in a net release. This
high secretion of FFA can be due to the higher metabolism of TG
and suggests that this molecule was not only up taken but also
metabolized. Overall, the CNSM equilibrates glucose intake with
a high fatty acid turnover and utilization.
Glycerol data showed no difference between static and dynamic
conditions (Figure 5C), as confirmed by our previous studies
(Vinci et al., 2010). Although the MSSM uptake was slightly more
than in the CNSM, it is likely that the glycerol balance is modulated
by the high triglyceride metabolism in the CNSM, rather than a
lack of glycerol movement.
Overall, the metabolic data show that the CNSM consumes
more glucose per cell while maintaining glucose levels closer to
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“normoglycemic” and has a higher level of fat metabolism and
corresponding metabolite turnover. These data were confirmed
by the assays on hepatic function. In fact, albumin concentra-
tion per cell was twice as much in the CNSM with respect to
the MSSM in both static and dynamic conditions, indicating that
cell cross-talk rather than the convective flow was the major dri-
ving force for the difference in albumin production (Figure 6A).
Urea production per cell was also higher in the CNSM then in the
MSSM (Figure 6B), and significantly upregulated by flow in both
models.
In summary, we show that changing the initial conditions in
a given multi-organ set-up can dramatically alter the metabolic
balance in the system. The reason for the difference is due to
the experimental set up, which will differ from device to device,
rather than the allometric considerations made per se when scal-
ing cell numbers or hepatic metabolism and vascular exchange
area. We also demonstrate that if designed and tested in a rigorous
manner, properly chosen cell ratios can be used to model some
features of human metabolism, as demonstrated for the CNSM.
We should, however, underline that in the MSSM we started off
assuming a metabolic in vitro model in the form of a hepatocyte
monolayer. This kind of organization is poorly correlated with
organs such as liver in which the three-dimensional hierarchical
structure is intimately linked with its metabolic function (Mad-
sen, 2012). Physiological barriers or tissues involved in transport
and exchange such as the endothelium, on the other hand, are bet-
ter correlated with a two-dimensional structure than a metabolic
organ.
This study demonstrates therefore that in vitro models of mul-
tiple organ systems need to be carefully designed and scaled,
within the limits of experimental and practical constraints, in
order to correctly represent physiological conditions. It also raises
questions about the physiological relevance of current emerging
integrative models and the scarcity of rational scaling and design
in many of the systems reported. Our data show that not only do
cross-talk and physical stimuli such as flow play an important role
within an in vitro model but the exact metabolic and numerical
relationship between cells is also crucial to recreate an appropriate
in vivo like environment in which cells can maintain a homeostatic
balance. In fact, if inappropriate or random scaling relationships
are employed, diseased states such as hyperplasia or other patholo-
gies manifested by anomalous relationships between cell numbers
or cell signaling, rather than physiological models, can be recreated
in vitro.
Finally, whatever model is used, the reader should bear in mind
that models are, by definition, simplified depictions of reality. In
this context, experimental in vitro models are necessarily a sim-
plification of the more complex living organism. A good scientist
should be aware of the limitations and boundary conditions of
such tests, being cautious about over-interpretation of results. In
fact, how accurately the experiments recapitulate in vivo condi-
tions depends on the study design as well as the questions being
posed and the desired outcomes.
CONCLUSION
Multi-organ models are the frontier of in vitro research. Our work
was driven by the great interest in developing new models capable
of recapitulating systemic and multiple pathway interaction, and
clearly shows that changing the relationships between cells in a
multi-organ or multi-tissue system can lead to results, which may
not be physiologically relevant, and even worse, incorrect.
This study provides new insights into advanced and rational
model design and is, as far as we know, the first investigation of
different cell ratios and allometric relationships between cells in a
multi-organ or multi-tissue in vitro system.
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